keyword
Keywords refractive errors in premature...

refractive errors in premature infants

https://read.qxmd.com/read/38432359/comparison-of-different-agents-and-doses-of-anti-vascular-endothelial-growth-factors-aflibercept-bevacizumab-conbercept-ranibizumab-versus-laser-for-retinopathy-of-prematurity-a-network-meta-analysis
#1
REVIEW
Amparo Ortiz-Seller, Pablo Martorell, Honorio Barranco, Isabel Pascual-Camps, Esteban Morcillo, José L Ortiz
Laser photocoagulation (LPC) and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections constitute the current standard treatment for retinopathy of prematurity (ROP). This network meta-analysis focus on whether a ranking of interventions may be established for different dose levels of intravitreal injection of anti-VEGF agents (aflibercept, bevacizumab, conbercept, ranibizumab) as primary treatments for ROP versus laser in terms of retreatment rate as primary outcome, and time to retreatment and refractive error as secondary endpoints, since best anti-VEGF dosage remains under debate...
March 1, 2024: Survey of Ophthalmology
https://read.qxmd.com/read/38212403/retinopathy-of-prematurity-screening-prevalence-and-risk-factors-of-ophthalmic-complications-in-non-treated-preterm-infants
#2
JOURNAL ARTICLE
Jacob I Strelnikov, Rakesh Rao, Shahriyar Majidi, Gregg Lueder, Andrew Lee, Margaret M Reynolds
INTRODUCTION: Retinopathy of prematurity (ROP) is a vision-threatening disease of premature infants. Practice guidelines recommend that all infants screened for ROP receive follow-up eye examinations to screen for ophthalmic complications.1 The purpose of this study was to identify risk factors for the development of strabismus, amblyopia, high refractive error, and cataracts among ROP-screened, non-treated infants. METHODS: Retrospective single-centre study of ROP-screened, non-treated premature infants with ophthalmic follow-up...
January 11, 2024: Eye
https://read.qxmd.com/read/38064668/five-year-visual-outcome-of-treatment-for-retinopathy-of-prematurity-in-infants-weighing-less-than-500-g-at-birth-a-multicenter-cohort-study-from-j-crest
#3
JOURNAL ARTICLE
Mizuki Tomioka, Tomoya Murakami, Fumiki Okamoto, Takamasa Kinoshita, Kayo Shinomiya, Tomo Nishi, Tatsuya Jujo, Shumpei Obata, Hideyuki Tsukitome, Shuntaro Ogura, Kaori Ueda, Ryota Ishii, Tetsuro Oshika
PURPOSE: To investigate the 5-year treatment outcomes of retinopathy of prematurity (ROP) in infants <500 g birth weight and compare laser and anti-vascular endothelial growth factor (VEGF) therapies. METHODS: A multicenter retrospective study comprised 24 eyes of 13 patients treated for type 1 ROP, followed for 5 years. Initial treatment was laser and anti-VEGF in 13 and 11 eyes, respectively. Data collected included sex, birth characteristics, ROP characteristics at the time of treatment, best-corrected visual acuity (BCVA), spherical equivalent (SE), and astigmatism at 5 years post-treatment...
December 6, 2023: Retina
https://read.qxmd.com/read/37221277/-late-sequelae-of-retinopathy-of-prematurity-in-infancy
#4
REVIEW
Jeany Q Li, Johanna M Pfeil, Andreas Stahl, Tim U Krohne
BACKGROUND: Retinopathy of prematurity (ROP) is one of the most frequent causes of severe visual impairment or blindness in childhood and can lead to severe late complications in children even after the initial disease has resolved. PURPOSE: The present study summarizes possible late effects in childhood after treated and untreated ROP. A special focus is on the development of myopia, retinal detachment, as well as neurological and pulmonary development after anti-vascular endothelial growth factor (VEGF) treatment...
May 23, 2023: Ophthalmologie
https://read.qxmd.com/read/36584135/association-between-myopia-progression-and-quantity-of-laser-treatment-for-retinopathy-of-prematurity
#5
JOURNAL ARTICLE
Eileen S Hwang, Iris S Kassem, Rawan Allozi, Sasha Kravets, Khalid Y Al-Kirwi, Joelle A Hallak, Deborah M Costakos
BACKGROUND: Previous studies found that infants with retinopathy of prematurity (ROP) who were treated for more posterior disease with a greater number of laser spots developed higher myopia. These studies included multiple physicians with variations in laser density. In treatments by a single physician, laser spot count is a better surrogate for area of avascular retina and anterior-posterior location of disease, so that the relationship with myopia can be better assessed. METHODS: Our retrospective study included infants treated with laser for ROP by a single surgeon at a single center...
2022: PloS One
https://read.qxmd.com/read/36102264/bibliometric-analysis-of-the-top-100-cited-articles-in-pediatric-ophthalmology
#6
JOURNAL ARTICLE
Marko Oydanich, Brian Schott, Rudolph S Wagner, Suqin Guo
PURPOSE: To determine and analyze the 100 most cited articles in pediatric ophthalmology. METHODS: A literature search was conducted using the ISI Web of Science database on the top 100 most cited articles in pediatric ophthalmology. RESULTS: The 100 most cited articles were published between 1941 and 2018, with the greatest number published in both 2005 and 2012. A total of 29,731 citations were generated during the study period. There has been a significant increase in citations annually since 1941, with a peak number of citations in 2021 with 2,629 citations...
September 14, 2022: Journal of Pediatric Ophthalmology and Strabismus
https://read.qxmd.com/read/35940211/long-term-outcomes-of-type-1-retinopathy-of-prematurity-following-monotherapy-with-bevacizumab-a-canadian-experience
#7
JOURNAL ARTICLE
Maram Isaac, Kamiar Mireskandari, Nicole Fallaha, Luis H Ospina, Eileen Javidi, Sarah Chorfi, Rosanne Superstein, Patrick Hamel, Nasrin N Tehrani
OBJECTIVE: To report long-term structural, visual, and refractive outcomes after monotherapy with intravitreal bevacizumab injection. DESIGN: Cohort retrospective chart review. PARTICIPANTS: A total of 56 premature infants with type 1 retinopathy of prematurity. METHODS: This is a chart review at 2 Canadian institutions. Inclusion criteria were single injection of 0.625 mg  intravitreal bevacizumab and minimum age at last follow-up of 3 years...
August 6, 2022: Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
https://read.qxmd.com/read/35922112/retrospective-evaluation-of-ophthalmological-and-neurological-outcomes-for-infants-born-before-24-weeks-gestational-age-in-a-swedish-cohort
#8
JOURNAL ARTICLE
Ann Hellström, Lena Jacobson, Abbas Al-Hawasi, Lena Hellström-Westas, Alexander Rakow, Mats Johnson, Karin Sävman, Gerd Holmstrom, Eva Larsson, Lotta Gränse, Marie Saric, Birgitta Sunnqvist, Lois Smith, Anna-Lena Hård, Eva Morsing, Pia Lundgren
OBJECTIVES: To retrospectively evaluate ophthalmological and neurological outcomes in a Swedish cohort of infants born before 24 weeks gestational age (GA) and explore risk factors for visual impairment. SETTING: Eye and paediatric clinics in Sweden. PARTICIPANTS: Infants screened for retinopathy of prematurity (ROP) (n=399), born before 24 weeks GA, 2007-2018. Cases were excluded if ophthalmological follow-up records could not be traced. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcomes were ophthalmological, including visual acuity (VA), refractive error, strabismus, nystagmus and cerebral visual impairment (CVI)...
August 3, 2022: BMJ Open
https://read.qxmd.com/read/35918972/profile-of-infantile-strabismus-at-a-tertiary-eye-care-center-in-india
#9
JOURNAL ARTICLE
Mariya Bashir Doctor, Virender Sachadeva, Ramesh Kekunnaya
Purpose: To study the profile, risk factors, and management outcomes of infantile strabismus at a tertiary eye care center. Methods: We prospectively analyzed the data of infants (children less than 1 year of age) who presented at our institute from August 2018 to December 2019. We excluded infants who did not complete a minimum follow-up of 6 months. Detailed meticulous history based on a set of standardized questionnaires was obtained and a comprehensive ophthalmological examination of the child was performed...
August 2022: Indian Journal of Ophthalmology
https://read.qxmd.com/read/35843486/late-vitreoretinal-complications-of-regressed-retinopathy-of-prematurity-retinal-break-vitreous-hemorrhage-and-retinal-detachment
#10
JOURNAL ARTICLE
Han-Tung Hsu, Eugene Yu-Chuan Kang, Michael P Blair, Michael Shapiro, Rahul Komati, Baker G Hubbard, Kenneth W Price, Antonio Capone, Kim A Drenser, Michael T Trese, Ryan Shields, Hiroyuki Kondo, Itsuka Matsushita, Yoshihiro Yonekawa, Samir N Patel, Shunji Kusaka, Fukutaro Mano, Karl R Olsen, Anna Ells, Atchara Amphornphruet, Mark K Walsh, Cagri G Besirli, Omar Moinuddin, Caroline R Baumal, Ana Bety Enriquez, Yih-Shiou Hwang, Chi-Chun Lai, Wei-Chi Wu
PURPOSE: To investigate the late vitreoretinal complications and visual outcomes in patients with regressed retinopathy of prematurity (ROP) with or without prior treatment. DESIGN: International, multicenter, noncomparative retrospective case series. PARTICIPANTS: We analyzed 264 eyes of 238 patients from 13 centers worldwide who developed vitreoretinal complications (retinal detachment [RD], vitreous hemorrhage [VH], or retinal break) at least 2 years after resolution of acute ROP...
July 14, 2022: Ophthalmology Retina
https://read.qxmd.com/read/35791141/exudative-retinal-detachment-as-an-initial-presentation-of-retinopathy-of-prematurity-clinical-profile-and-outcomes-of-a-rare-presentation
#11
JOURNAL ARTICLE
Komal Agarwal, Sushma Jayanna, Tapas Ranjan Padhi, Subhadra Jalali
Purpose: To describe the clinical profile and treatment outcomes of infants with retinopathy of prematurity (ROP) presenting with isolated exudative retinal detachment (ERD). Methods: Retrospective interventional case series. Preterm infants diagnosed with ROP with ERD at presentation were included. All demographic details, clinical findings, and treatment given were documented. The anatomical outcome was categorized as good, fair, and poor. Refractive outcome was classified into mild, moderate, and severe according to spherical equivalent at the last visit...
July 2022: Indian Journal of Ophthalmology
https://read.qxmd.com/read/35660415/low-and-very-low-dose-bevacizumab-for-retinopathy-of-prematurity-reactivations-additional-treatments-and-12-month-outcomes
#12
JOURNAL ARTICLE
Sharon F Freedman, Amra Hercinovic, David K Wallace, Raymond T Kraker, Zhuokai Li, Amit R Bhatt, Charline S Boente, Eric R Crouch, G Baker Hubbard, David L Rogers, Deborah VanderVeen, Michael B Yang, Nathan L Cheung, Susan A Cotter, Jonathan M Holmes
PURPOSE: Low-dose and very low-dose intravitreal bevacizumab (IVB) have been reported to be successful in short-term treatment of type 1 retinopathy of prematurity (ROP), down to an initial dose of 0.004 mg. We now report 12-month outcomes for these infants. DESIGN: Masked, multicenter, dose de-escalation study. PARTICIPANTS: One hundred twenty prematurely born infants with type 1 ROP. METHODS: A cohort of 120 infants with type 1 ROP in at least 1 eye from 2 sequential dose de-escalation studies of low-dose IVB (0...
June 1, 2022: Ophthalmology
https://read.qxmd.com/read/35579771/factors-associated-with-refractive-outcome-in-children-treated-with-bevacizumab-for-retinopathy-of-prematurity-the-importance-of-retinal-vascularization
#13
JOURNAL ARTICLE
Sadik Etka Bayramoglu, Nihat Sayin
PURPOSE: To evaluate the factors that may be associated with refractive outcome in eyes treated with intravitreal bevacizumab (IVB) injection for retinopathy of prematurity (ROP). METHODS: Retrospective case series. Refractive outcomes of 181 infants who were treated with primary IVB for Type I ROP or aggressive ROP, were retrospectively evaluated. According to the pretreatment retinal vascularization, eyes were classified into zone I, zone I-zone II, and zone II groups...
October 2022: International Ophthalmology
https://read.qxmd.com/read/35378056/long-term-visual-outcomes-of-children-screened-for-retinopathy-of-prematurity-with-telemedicine-in-new-zealand
#14
JOURNAL ARTICLE
Samantha K Simkin, Hannah M Kersten, Stuti L Misra, Charles Nj McGhee, Shuan Dai
CLINICAL RELEVANCE: Children with a history of regressed retinopathy of prematurity (ROP) are at increased risk of peripheral avascular retina. Wide-field digital retinal imaging and telemedicine is an effective tool for ROP screening. Ophthalmologists and Optometrists should have a high level of clinical suspicion for peripheral retinal changes in children screened for ROP. BACKGROUND: Retinopathy of prematurity, a vaso-proliferative disorder of the pre-term retina, is a preventable cause of childhood visual impairment...
April 4, 2022: Clinical & Experimental Optometry: Journal of the Australian Optometrical Association
https://read.qxmd.com/read/35367438/longitudinal-change-of-refractive-error-in-retinopathy-of-prematurity-treated-with-intravitreal-bevacizumab-or-laser-photocoagulation
#15
JOURNAL ARTICLE
Emily Wiecek, James D Akula, Deborah K Vanderveen, Iason S Mantagos, Carolyn Wu, Amber-Lee Curran, Hanna De Bruyn, Bridget Peterson, Anne B Fulton
PURPOSE: To compare progression of myopia and refractive error in former premature infants with retinopathy of prematurity (ROP) treated using intravitreal bevacizumab (IVB) or laser. DESIGN: Retrospective clinical cohort study. METHODS: We identified premature infants with ROP treated using IVB from 2011 to 2020 and compared their longitudinal cycloplegic refraction data to that of infants with ROP treated using laser during the same timeframe...
August 2022: American Journal of Ophthalmology
https://read.qxmd.com/read/35139693/effect-of-laser-photocoagulation-antiangiogenic-therapy-or-a-combined-treatment-on-refractive-outcomes-of-newborns-with-rop
#16
JOURNAL ARTICLE
María Catalina Del Portillo, Pedro Ivan Navarro, Daniela Duran, Juan Carlos Serrano
PURPOSE: To determine the refractive outcome after treatment with laser photocoagulation, intravitreal antiangiogenic injection or both, for the treatment of type 1 ROP and/or aggressive posterior ROP using defocus equivalent terms. These results will be compared with the spherical equivalent (SE) notation in an initial refraction (during the first 3 years after treatment) and in a final evaluation (three years after treatment). METHODS: Clinical charts review of preterm patients who developed type 1 ROP and/or aggressive posterior ROP who were treated with laser photocoagulation, intravitreal antiangiogenic injection, or both, between January 2007 and December 2014 at Fundación Oftalmológica de Santander were reviewed...
November 2022: European Journal of Ophthalmology
https://read.qxmd.com/read/35100244/anti-vascular-endothelial-growth-factor-vegf-drugs-compared-to-laser-photocoagulation-for-treatment-of-type-1-retinopathy-of-prematurity
#17
COMPARATIVE STUDY
Raúl González C, Marcela Díaz C, Rodolfo Garretón C
INTRODUCTION: Retinopathy of prematurity (ROP) is a condition that affects preterm infants, being the second leading cause of childhood blindness worldwide. The most commonly used treatments are cryotherapy or laser photocoagulation, but over the last few years, anti-vascular endothelial growth factor (anti-VEGF) drugs have gradually gained more adherents, mainly in the treatment of patients with type 1 retinopathy of prematurity (ET- ROP) Therefore, it is important to summarize the existing evidence to evaluate the efficacy and safety of anti-VEGF drugs in type 1 retinopathy of prematurity...
January 17, 2022: Medwave
https://read.qxmd.com/read/34937237/transscleral-vs-transpupillary-diode-laser-photocoagulation-for-the-treatment-of-zone-ii-type-1-retinopathy-of-prematurity-anatomical-and-refractive-outcomes
#18
JOURNAL ARTICLE
Ramak Roohipourmoallai, Shahin Faghihi, Hooshang Faghihi, Ali Torkashvand, Amin Nabavi, Marjan I Fooladi, Afsar D Farahani, Fatemeh Bazvand, Siva S R Iyer, Nazanin Ebrahimiadib
Purpose: To compare the anatomical and refractive outcomes of transscleral diode versus transpupillary laser photocoagulation for the treatment of zone II type 1 retinopathy of prematurity (ROP). Methods: In this prospective comparative interventional case series, infants with type 1 ROP in zone II were assigned to either transpupillary or transscleral laser based on the surgeons' expertise area. The rate of regression, need for retreatment, and structural and biometric outcomes at month 6 were evaluated and compared between the two treatment groups...
January 2022: Indian Journal of Ophthalmology
https://read.qxmd.com/read/34814873/refractive-errors-and-risk-factors-for-myopia-in-infants-aged-1-18-months-in-tianjin-china
#19
JOURNAL ARTICLE
Lu Huo, Yuanyuan Qi, Shaozhen Zhao
BACKGROUND: Infancy is the of a child's visual development. Refractive errors, especially myopia, are a common vision disorder. Thus, the purpose of this study was to explore refractive errors and risk factors for myopia among infants aged 1-18 months in Tianjin, China. METHODS: A total of 583 infants aged 1-18 months participated in this cross-sectional study at Tianjin Women's and Children's Health Center in China from February 2019 to November 2020. Each infant received a complete ophthalmologic examination, and myopia-related risk factors were investigated using a questionnaire...
November 23, 2021: BMC Ophthalmology
https://read.qxmd.com/read/34724137/scleral-buckling-surgery-for-stage-4a-and-4b-retinopathy-of-prematurity-in-critically-ill-neonates
#20
JOURNAL ARTICLE
Eleni Papageorgiou, Konstantina Riri, Dimitrios Kardaras, Ioanna Grivea, Asimina Mataftsi, Evangelia E Tsironi, Sofia Androudi
PURPOSE: To determine the efficacy of scleral buckling in eyes with stage 4A and 4B retinopathy of prematurity (ROP). METHODS: Seven eyes of five premature infants underwent scleral buckling for stage 4 ROP in zone II. Five eyes had stage 4A ROP, and two eyes had stage 4B ROP. Six eyes had previous diode laser photocoagulation, and one eye had received an intravitreal ranibizumab injection. Scleral buckling was the procedure of choice due to lack of access to specialized pediatric vitrectomy instrumentation...
April 2022: International Ophthalmology
keyword
keyword
97924
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.